دورية أكاديمية

Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile

التفاصيل البيبلوغرافية
العنوان: Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile
المؤلفون: Mauro, Francesca R., Molica, Stefano, Laurenti, Luca, Cortelezzi, Agostino, Carella, Angelo M., Zaja, Francesco, Chiarenza, Annalisa, Angrilli, Francesco, Nobile, Francesco, Marasca, Roberto, Musolino, Caterina, Brugiatelli, Maura, Piciocchi, Alfonso, Vignetti, Marco, Fazi, Paola, Gentile, Giuseppe, De Propris, Maria S., Starza, Irene Della, Marinelli, Marilisa, Chiaretti, Sabina, Del Giudice, Ilaria, Nanni, Mauro, Albano, Francesco, Cuneo, Antonio, Guarini, Anna, Foà, Robin
المصدر: In Leukemia Research February 2014 38(2):198-203
قاعدة البيانات: ScienceDirect
الوصف
تدمد:01452126
DOI:10.1016/j.leukres.2013.11.009